Get the Stockscreener App
22.49
4.34%
-1.02
Progyny Inc stock is traded at $22.49, with a volume of 1.21M.
It is down -4.34% in the last 24 hours and up +1.95% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$23.51
Open:
$23.49
24h Volume:
1.21M
Relative Volume:
1.13
Market Cap:
$1.93B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
35.70
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-2.68%
1M Performance:
+1.95%
6M Performance:
-2.93%
1Y Performance:
-17.01%
1-Day Range:
$22.36
$23.49
1-Week Range:
$22.36
$23.81
52-Week Range:
$13.39
$27.15
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
22.49 | 2.02B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
237.77 | 226.39B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
62.47 | 78.76B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
262.23 | 71.36B | 261.22B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
274.66 | 63.74B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
247.26 | 30.05B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Is Progyny Inc. stock overvalued or undervaluedCapitalize on market momentum for big wins - jammulinksnews.com
What are the latest earnings results for Progyny Inc.Unlock powerful portfolio optimization tools - jammulinksnews.com
What catalysts could drive Progyny Inc. stock higher in 2025High-octane gains - jammulinksnews.com
Is Progyny Inc. a growth stock or a value stockDiscover the next big stock winners - jammulinksnews.com
What makes Progyny Inc. stock price move sharplyRapid capital growth - jammulinksnews.com
What is the dividend policy of Progyny Inc. stockRapid portfolio appreciation - jammulinksnews.com
Does Progyny Inc. stock perform well during market downturnsBreakout stock performance - jammulinksnews.com
What analysts say about Progyny Inc. stockPhenomenal wealth increase - jammulinksnews.com
How does Progyny Inc. generate profit in a changing economyRobust investment performance - jammulinksnews.com
What is Progyny Inc. company’s growth strategyAchieve unparalleled market performance - jammulinksnews.com
What markets is USPH expanding into Is Progyny Inc. stock a good long term investment optionExponentially increasing returns - jammulinksnews.com
How does Progyny Inc. compare to its industry peersGet ahead with breakthrough trading ideas - jammulinksnews.com
What are the technical indicators suggesting about Progyny Inc.Accelerated investment success - jammulinksnews.com
At US$22.49, Is It Time To Put Progyny, Inc. (NASDAQ:PGNY) On Your Watch List? - simplywall.st
What are Progyny Inc. company’s key revenue driversAI Powered Target Finder For Consistent Profits - jammulinksnews.com
Progyny Inc's Study Highlights Women's Health Benefits Gap, a $1 Trillion Market Opportunity - AInvest
Progyny (PGNY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Hinge Health joins Progyny for pelvic floor therapy - MSN
Ranking Progyny Inc. among high performing stocks via toolsNews Based Entry Opportunity Alerts Detected - metal.it
How Progyny Inc. stock performs during market volatilityPotential Breakout Stock List Published This Week - beatles.ru
Candlestick signals on Progyny Inc. stock todayCapital Efficiency Optimized Stock Alerts Reviewed - metal.it
New Progyny Study Reveals Gap Between Perceptions and Realities - GuruFocus
Progyny and Dynata Release New Research Highlighting Gaps in Women’s Health Benefits in the Workplace - Quiver Quantitative
New Progyny Study Reveals Gap Between Perceptions and Realities in Women’s Health Benefits Coverage - GlobeNewswire
Women's Health Benefits Crisis: 81% of HR Leaders Think They're Delivering, But Only 52% of Women Agree - Stock Titan
Progyny, Inc. (PGNY) Stock Analysis: Unpacking the 15% Upside Potential and Analyst Consensus - DirectorsTalk Interviews
What risks could impact Progyny Inc. stock performanceTop Gaining Picks With Entry Signals Identified - metal.it
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
When is Progyny Inc. stock expected to show significant growthInvest smarter with daily stock recommendations - jammulinksnews.com
Sectors Driving Future Growth for Progyny Inc. StockHigh Return Intraday Picks - metal.it
Should You Think About Buying Progyny, Inc. (NASDAQ:PGNY) Now? - 富途牛牛
Progyny Inc. Stock Analysis and ForecastFree Technical Analysis Support - Autocar Professional
Why Progyny Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - beatles.ru
Should I buy Progyny Inc. stock before earningsUnstoppable trading performance - jammulinksnews.com
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):